Analytical Method Validation for Biopharmaceuticals: A Practical Guide - - BioPharm International

ADVERTISEMENT

Analytical Method Validation for Biopharmaceuticals: A Practical Guide


BioPharm International


References 1. FDA. 21 CFR 211, Sections 165(e) and 194(a)(2). Available at: http://www.fda.gov/.

2. PDA. Evaluation, validation and implementation of new microbiological testing methods: PDA Technical Report No. 33. PDA Journal of Pharmaceutical Science and Technology 2000; 54(Suppl. TR33).

3. ICH. Validation of Analytical Procedures. Q2A. Federal Register 1995; 60.

4. ICH. Validation of Analytical Procedures: methodology. Q2B. Federal Register 1996; 62.

5. United States Pharmacopoeia. USP 28 <1225>. Validation of Compendial Methods.

6. Krause SO. Development and validation of analytical methods for biopharmaceuticals, part I: development and optimization. BioPharm International 2004; 17(10):52-61.

7. Krause SO. Development and validation of analytical methods for biopharmaceuticals, part II: formal validation. BioPharm International 2004; 17(11):46-52.

8. CDER. Guidance for Industry. Bioanalytical Method Validation. Bethesda MD: FDA; 2001.

9. CBER. Draft Guidance for Industry. Analytical Procedures and Methods Validation. Bethesda MD: FDA; 2000.

10. Ritter N., et al. What is test method qualification? Proceedings of the WCBP CMC strategy forum, 24 July 2003. BioProcess International 2004; 2(8):32-47.

11. Krause SO. Good analytical method validation practice, part I: setting-up for compliance and efficiency. Journal of Validation Technology 2002; (9):23-32.

12. Krause SO. Good analytical method validation practice, part II: deriving acceptance criteria for the AMV protocol. Journal of Validation Technology 2003; (9):162-78.

13. Krause SO. Good analytical method validation practice, part III: data analysis and the AMV report. Journal of Validation Technology 2003; (10):21-36.

14. Krause SO. Analytical method validation. Presented at IVT's 10th Annual Meeting; 2004 Feb 25-28; Philadelphia, PA.

Stephan O. Krause, Ph.D., validation manager of QC assay support, Bayer HealthCare LLC, 800 Dwight Way, Berkeley, CA, 94701-1986, 510.705.4191,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Hospira Issues Recall Due to Mold Contamination
July 11, 2014
Baxter Issues Recall Due to Particulate Matter
July 11, 2014
FDA Publishes Guidance on ANDA Submissions
July 10, 2014
Biotech Industry Forms International Council
July 10, 2014
EMA Recommends 39 Drugs in First Half of 2014
July 10, 2014
Author Guidelines
Source: BioPharm International,
Click here